Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 USD | 0.00% | -3.23% | -95.72% |
May. 08 | Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation | CI |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Financials (USD)
Sales 2021 | 2.21M | Sales 2022 | 4.76M | Capitalization | 25.39M |
---|---|---|---|---|---|
Net income 2021 | -45M | Net income 2022 | -26M | EV / Sales 2021 | 31.5 x |
Net cash position 2021 | 20.53M | Net cash position 2022 | 433K | EV / Sales 2022 | 5.25 x |
P/E ratio 2021 |
-1.9
x | P/E ratio 2022 |
-0.96
x | Employees | 12 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.68% |
Latest transcript on DMK Pharmaceuticals Corporation
1 week | -3.23% | ||
Current month | -16.67% | ||
1 month | -14.29% | ||
3 months | -44.44% | ||
6 months | -94.33% | ||
Current year | -95.72% |
Managers | Title | Age | Since |
---|---|---|---|
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Seth Cohen
DFI | Director of Finance/CFO | 42 | 23-10-15 |
Robert H. Uhl
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Birndorf
BRD | Director/Board Member | 74 | 19-08-25 |
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Vickie Reed
BRD | Director/Board Member | 62 | 22-05-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.03 | 0.00% | 27,906 |
24-05-24 | 0.03 | 0.00% | 34,844 |
24-05-23 | 0.03 | -30.23% | 103,022 |
24-05-22 | 0.043 | +38.71% | 3,673 |
24-05-21 | 0.031 | -11.17% | 6,557 |
Delayed Quote OTC Markets, May 28, 2024 at 03:56 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-95.72% | 303K | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- DMKPQ Stock